The addition of linear ablation plus ethanol infusion to pulmonary vein isolation (PVI) improves control of persistent atrial fibrillation (AF) better than PVI alone, a multicenter randomized trial ...

For patients undergoing catheter ablation for persistent atrial fibrillation (AF), cryoballoon and radiofrequency catheters are both effective in achieving pulmonary vein isolation (PVI). And the ...

New research shows that cryoablation is a safe and effective approach to close congenital patent foramen ovale (PFO, a small hole in the heart) in patients with atrial fibrillation (AF) undergoing ...

TCTMD reported in-depth on the TAILORED-AF trial, May 29, 2024, at the HRS 2024 meeting. The full manuscript was subsequently published in Nature Medicine on February 14, 2025. The published results ...

LONDON -- Pulmonary vein isolation (PVI) produced real short-term improvements for people with atrial fibrillation (Afib or AF), according to the first sham-controlled trial on the subject. Continuous ...

London, United Kingdom – 2 September 2024: A catheter ablation procedure widely used to treat the most common heart rhythm disorder significantly reduces the burden of atrial fibrillation (AF) and ...

MARLBOROUGH, Mass.--(BUSINESS WIRE)--CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for cardiac arrhythmias, today announced the publication of the 12-month ...

A catheter ablation procedure widely used to treat the most common heart rhythm disorder significantly reduces the burden of atrial fibrillation (AF) and results in clinically important improvements ...

Aggressive ablation provided more favorable outcomes at 12 months than regular ablation in patients with persistent atrial fibrillation (AF). Patients undergoing aggressive ablation also had enhanced ...

Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of the novel nPulse™ technology using proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced late-breaking ...